References
- 1. Bratina NU, Tahirović H, Battelino T, Krzisnik C. Incidence of childhoodonset Type I diabetes in Slovenia and the Tuzia region (Bosnia and Herzegovina) in the period 1990-1998. Diabetologia 2001; 44(Suppl 3): B27-31.
- 2. Patterson CC, Gyürüs E, Rosenbauer J, Cinek O, Neu A. et al. Trends in childhood type 1 diabetes incidence in Europe during 1989-2008: evidence of non-uniformity over time in rates of increase. Diabetologia 2012; 55: 2142-7.
- 3. Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G, EURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009; 373: 2027-33.
- 4. Radosevic B, Bukara-Radujkovic G, Miljkovic V, Pejicic S, Bratina N, Battelino T. The incidence of type 1 diabetes in Republic of Srpska (Bosnia and Herzegovina) and Slovenia in the period 1998-2010. Pediatr Diabetes 2013; 14: 273-9.
- 5. Blumenfeld O, Dichtiar R, Shohat T, Israel IDDM Registry Study Group (IIRSG). Trends in the incidence of type 1 diabetes among Jews and Arabs in Israel. Pediatr Diabetes 2014; 15: 422-7.
- 6. Vehik K, Hamman RF, Lezotte D, Norris JM, Klingensmith GJ, Dabelea D. Childhood growth and age at diagnosis with Type 1 diabetes in Colorado young people. Diabet Med 2009; 26: 961-7.
- 7. Ehehalt S, Dietz K, Willasch AM, Neu A, DIARY-Group Baden- Wuerttemberg. Prediction model for the incidence and prevalence of type 1 diabetes in childhood and adolescence: evidence for a cohortdependent increase within the next two decades in Germany. Pediatr Diabetes 2012; 13: 15-20.
- 8. Krasevec A. Newly discovered diabetes in children and adolescent in Slovenia: review and analyses of epidemiological and clinical data: master degree thesis. Ljubljana: Visoka šola za zdravstvo, 2013: 1-33.
- 9. Laron Z, Galatzer A, Amir S, Gil R, Karp M, Mimouni M. A multidisciplinary, comprehensive, ambulatory treatment scheme for diabetes mellitus in children. Diabetes Care 1979; 2: 342-8.
- 10. Kržišnik C, Bratanič N, Brus L. The current treatment of children and adolescents with insulin dependent diabetes in Slovenia. Zdrav Vest 1990; 59: 67-9.
- 11. Matajc L. Diabetes mellitus infantilis et juvenilis . Sladkorčki 1979: 1-49.
- 12. DCCT Research Group. The effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: the diabetes control and complications trial. J Pediatr 1994; 125: 177-88.
- 13. Danne T, Bangstad HJ, Deeb L, Jarosz-Chobot P, Mungaie L, Saboo B. et al. Insulin treatment in children and adolescents with diabetes. Pediatr Diabetes 2014; 15(Suppl 20): 115-34.
- 14. Holl RW, Swift PG, Mortensen HB, Lynggaard H, Hougaard P, Aanstoot HJ. et al. Insulin injection regimens and metabolic control in an international survey of adolescents with type 1 diabetes over 3 years: results from the Hvidore study group. Eur J Pediatr 2003; 162: 22-9.
- 15. Pihoker C, Badaru A, Anderson A, Morgan T, Dolan L, Dabelea D. et al. Insulin regimens and clinical outcomes in a type 1 diabetes cohort: the search for diabetes in youth study. Diabetes Care 2013; 36: 27-33.
- 16. Shalitin S, Ben-Ari T, Yackobovitch-Gavan M, Tenenbaum A, Lebenthal Y, de Vries L. et al. Using the internet-based upload blood glucose monitoring and therapy management system in patients with type 1 diabetes. Acta Diabetol 2014; 51: 247-56.
- 17. Smart CE, Annan F, Bruno LP, Higgins LA, Acerini CL. Nutritional management in children and adolescents with diabetes. Pediatr Diabetes 2014; 15(Suppl 20): 135-53.
- 18. Hoey H, Hvidoere Study Group on Childhood Diabetes. Psychosocial factors are associated with metabolic control in adolescents: research from the Hvidoere Study Group on Childhood Diabetes. Pediatr Diabetes 2009; 10(Suppl 13): 9-14.
- 19. Shorer M, David R, Schoenberg-Taz M, Levavi-Lavi I, Phillip M, Meyerovitch J. Role of parenting style in achieving metabolic control in adolescents with type 1 diabetes. Diabetes Care 2011; 34: 1735-7.
- 20. Wigert H, Wikström E. Organizing person-centred care in paediatric diabetes: multidisciplinary teams, long-term relationships and adequate documentation. BMC Res Notes 2014; 7: 72.
- 21. Shalitin S, Gil M, Nimri R, de Vries L, Gavan MY, Phillip M. Predictors of glycaemic control in patients with Type 1 diabetes commencing continuous subcutaneous insulin infusion therapy. Diabet Med 2010; 27: 339-47.
- 22. Wolfsdorf JI, Allgrove J, Craig ME, Edge J, Glaser N, Jain V. et al. Diabetic ketoacidosis and hyperglycemic hypersmolar state. Pediatric Diabetes 2014; 15(Suppl 20): 154-79.
- 23. Ly TT, Maahs DM, Rewers A, Dunger D, Oduwole A, Jones TW. Assessment and management of Hypoglycemia. Pediatric Diabetes 2014; 15(Suppl 20): 180-92.
- 24. Dovc K, Telic SS, Lusa L, Bratanic N, Zerjav-Tansek M, Kotnik P. et al. Improved metabolic control in pediatric patients with type 1 diabetes: a nationwide prospective 12-year time trends analysis. Diabetes Technol Ther 2014; 16: 33-40.
- 25. Swift PG. Diabetes education in children and adolescents. Pediatr Diabetes 2009; 10(Suppl 12): 51-7.
- 26. Bratina N, Battelino T. Insulin pumps and continuous glucose monitoring (CGM) in preschool and school-age children: how schools can integrate technology. Pediatr Endocrinol Rev 2010; 7(Suppl 3): 417-21.
- 27. Shalitin S, Lahav-Ritte T, Lebenthal Y, Devries L, Phillip M. Does the timing of insulin pump therapy initiation after type 1 diabetes onset have an impact on glycemic control? Diabetes Technol Ther 2012; 14: 389-97.
- 28. Tamborlane WV, Fredrickson LP, Ahern JH. Insulin pump therapy in childhood diabetes mellitus: guidelines for use. Treat Endocrinol 2003; 2: 11-21.
- 29. de Vries L, Grushka Y, Lebenthal Y, Shalitin S, Phillip M. Factors associated with increased risk of insulin pump discontinuation in pediatric patients with type 1 diabetes. Pediatr Diabetes 2011; 12: 506-12.
- 30. Phillip M, Danne T, Shalitin S, Buckingham B, Laffel L, Battelino T. et al. Use of continuous glucose monitoring in children and adolescents. Pediatr Diabetes 2012; 13: 215-28.
- 31. Nørgaard K, Scaramuzza A, Bratina N, Lalić NM, Jarosz-Chobot P, Kocsis G. et al. Routine sensor-augmented pump therapy in type 1 diabetes: the INTERPRET study. Diabetes Technol Ther 2013; 15: 273-80.
- 32. Shalitin S, Phillip M. Hypoglycemia in type 1 diabetes: a still unresolved problem in the era of insulin analogs and pump therapy. Diabetes Care 2008; 31(Suppl 2): S121-4.
- 33. Battelino T, Bolinder J. Clinical use of real-time continuous glucose monitoring. Curr Diabetes Rev 2008; 4: 218-22.
- 34. Battelino T, Conget I, Olsen B, Schütz-Fuhrmann I, Hommel E, Hoogma R. et al. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia 2012; 55: 3155-62.
- 35. Battelino T, Phillip M. Real-time continuous glucose monitoring in randomized control trials. Pediatr Endocrinol Rev 2010; 7(Suppl 3): 401-4.
- 36. Battelino T, Phillip M, Bratina N, Nimri R, Oskarsson P, Bolinder J. Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care 2011; 34: 795-800.
- 37. Hommel E, Olsen B, Battelino T, Conget I, Schütz-Fuhrmann I, Hoogma R. et al. Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study. Acta Diabetol 2014; 51: 845-51.
- 38. Bode BW, Battelino T. Continuous glucose monitoring in 2012. Diabetes Technol Ther 2013; 15(Suppl 1): S13-23.
- 39. Battelino T, Bode BW. Continuous glucose monitoring in 2013. Diabetes Technol Ther 2014; 16(Suppl 1): S11-6.
- 40. Ludvigsson J, Krisky D, Casas R, Battelino T, Castaño L, Greening J. et al. GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus. N Engl J Med 2012; 366: 433-42.
- 41. Nimri R, Lebenthal Y, Shalitin S, Benzaquen H, Demol S, Phillip M. Metabolic control by insulin detemir in basal-bolus therapy: treat-totarget study in children and adolescents with type 1 diabetes. Pediatr Diabetes 2013; 14: 196-202.
- 42. Klein DJ, Battelino T, Chatterjee DJ, Jacobsen LV, Hale PM, Arslanian S. et al. Liraglutide’s safety, tolerability, pharmacokinetics, and pharmacodynamics in pediatric type 2 diabetes: a randomized, double-blind, placebo-controlled trial. Diabetes Technol Ther 2014; 16: 679-87.
- 43. Lebenthal Y, Lazar L, Benzaquen H, Shalitin S, Phillip M. Patient perceptions of using the OmniPod system compared with conventional insulin pumps in young adults with type 1 diabetes. Diabetes Technol Ther 2012; 14: 411-7.
- 44. Buse JB, Kudva YC, Battelino T, Davis SN, Shin J, Welsh JB. Effects of sensor-augmented pump therapy on glycemic variability in wellcontrolled type 1 diabetes in the STAR 3 study. Diabetes Technol Ther 2012; 14: 644-7.
- 45. Adolfsson P, Veijola R, Huot C, Hansen HD, Lademann JB, Phillip M. Safety and patient perception of an insulin pen with simple memory function for children and adolescents with type 1 diabetes--the REMIND study. Curr Med Res Opin 2012; 28: 1455-63.
- 46. Liberman A, Buckingham B, Phillip M. Diabetes technology and the human factor. Int J Clin Pract 2011; (Suppl 170): 83-90.
- 47. Radobuljac MD, Bratina NU, Battelino T, Tomori M. Lifetime prevalence of suicidal and self-injurious behaviors in a representative cohort of Slovenian adolescents with type 1 diabetes. Pediatr Diabetes 2009; 10: 424-31.
- 48. Hovnik T, Dolzan V, Bratina NU, Podkrajsek KT, Battelino T. Genetic polymorphisms in genes encoding antioxidant enzymes are associated with diabetic retinopathy in type 1 diabetes. Diabetes Care 2009; 32: 2258-62.
- 49. Battelino N, Sebestjen M, Keber I, Blagus R, Hovnik T, Bratina N. et al. Endothelial nitric oxide synthase T(-786)C polymorphism in children and adolescents with type 1 diabetes and impaired endotheliumdependent dilatation. Horm Res Paediatr 2011; 76: 248-53.
- 50. Gozlan Y, Tenenbaum A, Shalitin S, Lebenthal Y, Oron T, Cohen O. et al. The glucokinase mutation p.T206P is common among MODY patients of Jewish Ashkenazi descent. Pediatr Diabetes 2012; 13: e14-21.
- 51. Bratanic N, Smigoc Schweiger D, Mendez A, Bratina N, Battelino T, Vidan-Jeras B. An influence of HLA-A, B, DR, DQ, and MICA on the occurrence of Celiac disease in patients with type 1 diabetes. Tissue Antigens 2010; 76: 208-15.
- 52. Smigoc Schweiger D, Mendez A, Kunilo Jamnik S, Bratanic N, Bratina N, Battelino T. et al. Genetic risk for co-occurrence of type 1 diabetes and celiac disease is modified by HLA-C and killer immunoglobulin-like receptors. Tissue Antigens 2014; 84: 471-8.
- 53. Danne T, Lion S, Madaczy L, Veeze H, Raposo F, Rurik I. et al. Criteria for Centers of Reference for pediatric diabetes: an European perspective. Pediatr Diabetes 2012; 13(Suppl 16): 62-75.
- 54. Nimri R, Danne T, Kordonouri O, Atlas E, Bratina N, Biester T. et al. The “Glucositter” overnight automated closed loop system for type 1 diabetes: a randomized crossover trial. Pediatric Diabetes 2013; 14: 159-67.
- 55. Phillip M, Battelino T, Atlas E, Kordonouri O, Bratina N, Miller S. et al. Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med 2013; 368: 824-33.
- 56. Nimri R, Muller I, Atlas E, Miller S, Fogel A, Bratina N. et al. MD-Logic overnight control for 6 weeks of home use in patients with type 1 diabetes: randomized crossover trial. Diabetes Care 2014; 37: 3025-32.
- 57. Nimri R, Muller I, Atlas E, Miller S, Kordonouri O, Bratina N. et al. Night glucose control with MD-Logic artificial pancreas in home setting: a single blind, randomized crossover trial-interim analysis. Pediatr Diabetes 2014; 15: 91-9.